CN105612155A - 治疗局部疼痛的组合物和方法 - Google Patents

治疗局部疼痛的组合物和方法 Download PDF

Info

Publication number
CN105612155A
CN105612155A CN201380030659.5A CN201380030659A CN105612155A CN 105612155 A CN105612155 A CN 105612155A CN 201380030659 A CN201380030659 A CN 201380030659A CN 105612155 A CN105612155 A CN 105612155A
Authority
CN
China
Prior art keywords
pain
pharmaceutical composition
composition
treatment
dispenser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380030659.5A
Other languages
English (en)
Chinese (zh)
Inventor
M·坎杜拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of CN105612155A publication Critical patent/CN105612155A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
CN201380030659.5A 2012-05-10 2013-02-16 治疗局部疼痛的组合物和方法 Pending CN105612155A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1843/CHE/2012 2012-05-10
IN1843CH2012 2012-05-10
PCT/IB2013/051268 WO2013168006A2 (fr) 2012-05-10 2013-02-16 Compositions et méthodes de traitement de la douleur locale

Publications (1)

Publication Number Publication Date
CN105612155A true CN105612155A (zh) 2016-05-25

Family

ID=54193695

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380030659.5A Pending CN105612155A (zh) 2012-05-10 2013-02-16 治疗局部疼痛的组合物和方法

Country Status (8)

Country Link
EP (1) EP2882745A2 (fr)
JP (1) JP2016508956A (fr)
CN (1) CN105612155A (fr)
AU (1) AU2013257727B2 (fr)
CA (1) CA2873138A1 (fr)
SG (1) SG11201407323WA (fr)
WO (1) WO2013168006A2 (fr)
ZA (1) ZA201408055B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
IL238516B (en) 2012-11-05 2022-08-01 Relievant Medsystems Inc System and methods for creating curved pathways through bone and regulating the nerves within the bone
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
BR112019013192A2 (pt) * 2016-12-26 2019-12-10 Cellix Bio Private Ltd composto e composição farmacêutica
CA3150339A1 (fr) 2019-09-12 2021-03-18 Brian W. Donovan Systemes et methodes de modulation de tissu

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1126435A (zh) * 1993-06-28 1996-07-10 阿斯特拉公司 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用
CN1187813A (zh) * 1995-05-01 1998-07-15 斯科舍集团有限公司 作为生物活性化合物的脂肪酸酯
CN1279607A (zh) * 1997-11-19 2001-01-10 达尔文发现有限公司 麻醉制剂
CN101842099A (zh) * 2008-04-18 2010-09-22 华沙整形外科股份有限公司 包括局部麻醉药的治疗术后痛的方法和组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4880190B2 (ja) * 2001-04-30 2012-02-22 トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル 医薬として活性なウリジンエステル
EP2209450A4 (fr) * 2007-11-07 2013-09-25 Svip5 Llc Libération lente de sels organiques d'anesthésique local pour un soulagement de la douleur
WO2013024320A1 (fr) * 2011-08-17 2013-02-21 Mahesh Kandula Dérivés de 2,6-xylidine pour le traitement de la douleur

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1126435A (zh) * 1993-06-28 1996-07-10 阿斯特拉公司 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用
CN1187813A (zh) * 1995-05-01 1998-07-15 斯科舍集团有限公司 作为生物活性化合物的脂肪酸酯
CN1279607A (zh) * 1997-11-19 2001-01-10 达尔文发现有限公司 麻醉制剂
CN101842099A (zh) * 2008-04-18 2010-09-22 华沙整形外科股份有限公司 包括局部麻醉药的治疗术后痛的方法和组合物

Also Published As

Publication number Publication date
AU2013257727A1 (en) 2014-11-27
CA2873138A1 (fr) 2013-11-14
SG11201407323WA (en) 2014-12-30
JP2016508956A (ja) 2016-03-24
AU2013257727B2 (en) 2016-04-28
ZA201408055B (en) 2016-03-30
WO2013168006A3 (fr) 2016-09-01
WO2013168006A2 (fr) 2013-11-14
EP2882745A2 (fr) 2015-06-17

Similar Documents

Publication Publication Date Title
CN104603090A (zh) 治疗代谢综合征的组合物和方法
CN104583182A (zh) 用于治疗粘膜炎的组合物和方法
CN105612155A (zh) 治疗局部疼痛的组合物和方法
CN101247795B (zh) 用于治疗与中枢神经系统（cns）相关疾病的方法和组合物
CN102579350B (zh) 右旋布洛芬脂质体固体制剂
KR101865194B1 (ko) 아라키돈산 유사체 및 이를 사용한 진통제 치료 방법
WO2013024376A1 (fr) Compositions et procédés pour le traitement de l'athérotrombose
CN104603100A (zh) 用于治疗炎症性肠病的组合物和方法
SK36393A3 (en) Biphasic relase formulations for lipophilic drugs and method
KR102180667B1 (ko) 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
CN104364241A (zh) 抑制碳酸酐酶活性的组合物和方法
JPS62501845A (ja) 制御放出塩化カリウム
CN104603096A (zh) 用于治疗神经肌肉障碍和神经退行性疾病的组合物和方法
US11896598B2 (en) Appetite suppressant compositions and methods thereof
CN107207403A (zh) 用于治疗多发性硬化的组合物和方法
CN104603097A (zh) 用于治疗多发性硬化症的组合物和方法
CN101270052B (zh) 丁香酚阿斯匹林酯药用化合物及其制剂和制备方法
CN104583162A (zh) 治疗中度至重度疼痛的组合物和方法
CN104350041A (zh) 用于治疗神经系统疾病的组合物和方法
CN104797568A (zh) 用于治疗神经障碍的组合物和方法
CN104364230A (zh) 用于治疗糖尿病的组合物和方法
CA3074541C (fr) Compositions de suppression de l`appetit et methodes connexes
CN105407884B (zh) 降低甘油三酯、总胆固醇和低密度脂蛋白血液浓度的方法
CN1810236A (zh) 大蒜素的脂质体制剂
CN104379589A (zh) 抗血小板药剂的前药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160525